These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

699 related articles for article (PubMed ID: 16951005)

  • 41. Long-term evaluation following resection of apparently benign pheochromocytoma(s)/paraganglioma(s).
    van Heerden JA; Roland CF; Carney JA; Sheps SG; Grant CS
    World J Surg; 1990; 14(3):325-9. PubMed ID: 1973322
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Probability of positive genetic testing in patients diagnosed with pheochromocytoma and paraganglioma: Criteria beyond a family history.
    Alobuia WM; Ammar S; Tyagi M; Ghosh C; Gunda V; Annes JP; Kebebew E
    Surgery; 2021 Feb; 169(2):298-301. PubMed ID: 33023754
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Global and regional CpG methylation in pheochromocytomas and abdominal paragangliomas: association to malignant behavior.
    Geli J; Kiss N; Karimi M; Lee JJ; Bäckdahl M; Ekström TJ; Larsson C
    Clin Cancer Res; 2008 May; 14(9):2551-9. PubMed ID: 18451216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators.
    Ayala-Ramirez M; Feng L; Johnson MM; Ejaz S; Habra MA; Rich T; Busaidy N; Cote GJ; Perrier N; Phan A; Patel S; Waguespack S; Jimenez C
    J Clin Endocrinol Metab; 2011 Mar; 96(3):717-25. PubMed ID: 21190975
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preoperative genetic testing in pheochromocytomas and paragangliomas influences the surgical approach and the extent of adrenal surgery.
    Nockel P; El Lakis M; Gaitanidis A; Yang L; Merkel R; Patel D; Nilubol N; Prodanov T; Pacak K; Kebebew E
    Surgery; 2018 Jan; 163(1):191-196. PubMed ID: 29126554
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Paraganglioma: the role of genetic counselling and radiological screening.
    Dundee P; Clancy B; Wagstaff S; Briggs R
    J Clin Neurosci; 2005 May; 12(4):464-6. PubMed ID: 15925783
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surgical Treatment of Malignant Pheochromocytoma and Paraganglioma: Retrospective Case Series.
    Strajina V; Dy BM; Farley DR; Richards ML; McKenzie TJ; Bible KC; Que FG; Nagorney DM; Young WF; Thompson GB
    Ann Surg Oncol; 2017 Jun; 24(6):1546-1550. PubMed ID: 28058556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of pheochromocytomas / paragangliomas from Eastern Slovakia.
    Felsoci M; Lazurova I; Wagnerova H; Svajdler M
    Neoplasma; 2013; 60(4):452-8. PubMed ID: 23581419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glomus tumors in patients of advanced age: a conservative approach.
    Cosetti M; Linstrom C; Alexiades G; Tessema B; Parisier S
    Laryngoscope; 2008 Feb; 118(2):270-4. PubMed ID: 18030172
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Surgery of retroperitoneal pheochromocytoma].
    Duff C; van Segesser L; Schmid ER; Ziegler W; Turina M
    Helv Chir Acta; 1989 Jun; 56(1-2):151-3. PubMed ID: 2777597
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas.
    Lebuffe G; Dosseh ED; Tek G; Tytgat H; Moreno S; Tavernier B; Vallet B; Proye CA
    Anaesthesia; 2005 May; 60(5):439-44. PubMed ID: 15819762
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New advances in the genetics of pheochromocytoma and paraganglioma syndromes.
    Gimenez-Roqueplo AP
    Ann N Y Acad Sci; 2006 Aug; 1073():112-21. PubMed ID: 17102078
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas.
    Havekes B; van der Klaauw AA; Weiss MM; Jansen JC; van der Mey AG; Vriends AH; Bonsing BA; Romijn JA; Corssmit EP
    Endocr Relat Cancer; 2009 Jun; 16(2):527-36. PubMed ID: 19289533
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas.
    Oh DY; Kim TW; Park YS; Shin SJ; Shin SH; Song EK; Lee HJ; Lee KW; Bang YJ
    Cancer; 2012 Dec; 118(24):6162-70. PubMed ID: 22736481
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute.
    Huang KH; Chung SD; Chen SC; Chueh SC; Pu YS; Lai MK; Lin WC
    Int J Urol; 2007 Mar; 14(3):181-5. PubMed ID: 17430251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Diagnosis of and surgical therapy for pheochromocytoma and paraganglioma].
    Musholt TJ
    Zentralbl Chir; 2010 Jun; 135(3):226-32. PubMed ID: 20549585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retroperitoneal sarcomas in children: outcomes from an institution.
    Pham TH; Iqbal CW; Zarroug AE; Donohue JH; Moir C
    J Pediatr Surg; 2007 May; 42(5):829-33. PubMed ID: 17502193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oncologic aspects of pheochromocytoma: the importance of follow-up.
    Scott HW; Halter SA
    Surgery; 1984 Dec; 96(6):1061-6. PubMed ID: 6505959
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Malignant pheochromocytomas and paragangliomas: molecular signaling pathways and emerging therapies.
    Santarpia L; Habra MA; Jiménez C
    Horm Metab Res; 2009 Sep; 41(9):680-6. PubMed ID: 19343618
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Genetic background of tumors originating from adrenomedullar and extraadrenal chromaffin tissue--update].
    Vanuga P; Pura M; Kreze A
    Vnitr Lek; 2010 Dec; 56(12):1296-302. PubMed ID: 21261119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.